Anthony A. Donato, MD, MHPE
Learn more about subscription options.
Register Now for a free account.
Donato AA. Semaglutide reduced a composite of CV events at 2 years in patients with type 2 diabetes and high CV risk. Ann Intern Med. 2017;166:JC8. doi: 10.7326/ACPJC-2017-166-2-008
Download citation file:
Published: Ann Intern Med. 2017;166(2):JC8.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Prevention/Screening.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only